Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 study.
- DOI
- 10.1007/s10147-026-03067-2
- Published
- 2026 Aug
- Container
- International journal of clinical oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-026-03067-2,
title = {Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 study.},
author = {Shin Y and Makiyama A and Yamada T and Kashiwada T and Hattori M and Yamaguchi T and Shindo Y and Kawazoe T and Nambara S and Tsuda Y and Nakanoko T and Ando K and Yoshizumi T and Sakai K and Nishio K and Oki E},
year = {2026},
journal = {International journal of clinical oncology},
doi = {10.1007/s10147-026-03067-2},
url = {https://doi.org/10.1007/s10147-026-03067-2}
}RIS
TY - JOUR TI - Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 study. AU - Shin Y AU - Makiyama A AU - Yamada T AU - Kashiwada T AU - Hattori M AU - Yamaguchi T AU - Shindo Y AU - Kawazoe T AU - Nambara S AU - Tsuda Y AU - Nakanoko T AU - Ando K AU - Yoshizumi T AU - Sakai K AU - Nishio K AU - Oki E PY - 2026 JO - International journal of clinical oncology DO - 10.1007/s10147-026-03067-2 UR - https://doi.org/10.1007/s10147-026-03067-2 ER -
APA
Y, S., A, M., T, Y., T, K., M, H., T, Y., Y, S., T, K., S, N., Y, T., T, N., K, A., T, Y., K, S., K, N., & E, O. (2026). Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 study.. International journal of clinical oncology. https://doi.org/10.1007/s10147-026-03067-2
Source records
- pubmed · retrieved 2026-09-26T09:12:22.609Z